Bovine tuberculosis is a costly cattle disease that primarily affects low and middle-income countries. More than 50 million cattle are infected every year, costing an estimated US$3 billion annually.
VIDO-InterVac has established itself as a leading global institute in protecting human and animal health since 1975, with six world-firsts among the eight vaccines it has commercialized.
Following an international search, Dr. Volker Gerdts has been selected to lead the University of Saskatchewan’s Vaccine and Infectious Disease Organization-International Vaccine Centre.
